The Advanced Lung Cancer Inflammation Index (ALI), which combines body mass index, serum albumin, and neutrophil–lymphocyte ratio, has been linked to outcomes in chronic diseases, but its relationship with bone turnover markers (BTMs) in OPF remains unclear. The gene discussed is ALB; the disease is lung cancer.